185 related articles for article (PubMed ID: 32353110)
1. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.
Alexandre J; Salem JE; Moslehi J; Sassier M; Ropert C; Cautela J; Thuny F; Ederhy S; Cohen A; Damaj G; Vilque JP; Plane AF; Legallois D; Champ-Rigot L; Milliez P; Funck-Brentano C; Dolladille C
Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):312-320. PubMed ID: 32353110
[TBL] [Abstract][Full Text] [Related]
2. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
Salem JE; Nguyen LS; Moslehi JJ; Ederhy S; Lebrun-Vignes B; Roden DM; Funck-Brentano C; Gougis P
Eur Heart J; 2021 Oct; 42(38):3915-3928. PubMed ID: 34370839
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation in patients treated with intravenous zoledronic or pamidronic acid: a pharmacoepidemiological study.
Pijnenburg L; Salem JE; Lebrun-Vignes B; Sibilia J; Javier RM; Arnaud L
Eur J Endocrinol; 2021 Mar; 184(3):437-444. PubMed ID: 33449911
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer Drugs Associated Atrial Fibrillation-An Analysis of Real-World Pharmacovigilance Data.
Ahmad J; Thurlapati A; Thotamgari S; Grewal US; Sheth AR; Gupta D; Beedupalli K; Dominic P
Front Cardiovasc Med; 2022; 9():739044. PubMed ID: 35498039
[TBL] [Abstract][Full Text] [Related]
5. Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database.
Dumont A; Dolladille C; de Boysson H; Alexandre J; Nguyen A; Deshayes S; Aouba A
Autoimmun Rev; 2022 Sep; 21(9):103157. PubMed ID: 35902047
[TBL] [Abstract][Full Text] [Related]
6. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitors and Venous Thromboembolism: An Analysis of the WHO Pharmacovigilance Database.
Allouchery M; Beuvon C; Pérault-Pochat MC; Roblot P; Puyade M; Martin M
Clin Pharmacol Ther; 2022 Jul; 112(1):164-170. PubMed ID: 35426120
[TBL] [Abstract][Full Text] [Related]
8. SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system.
Bonora BM; Raschi E; Avogaro A; Fadini GP
Cardiovasc Diabetol; 2021 Feb; 20(1):39. PubMed ID: 33573667
[TBL] [Abstract][Full Text] [Related]
9. Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics.
Patras de Campaigno E; Bondon-Guitton E; Laurent G; Montastruc F; Montastruc JL; Lapeyre-Mestre M; Despas F
Br J Clin Pharmacol; 2017 Jul; 83(7):1544-1555. PubMed ID: 28098949
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase.
Xiao L; Salem JE; Clauss S; Hanley A; Bapat A; Hulsmans M; Iwamoto Y; Wojtkiewicz G; Cetinbas M; Schloss MJ; Tedeschi J; Lebrun-Vignes B; Lundby A; Sadreyev RI; Moslehi J; Nahrendorf M; Ellinor PT; Milan DJ
Circulation; 2020 Dec; 142(25):2443-2455. PubMed ID: 33092403
[TBL] [Abstract][Full Text] [Related]
11. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
12. Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study.
Bretagne M; Lebrun-Vignes B; Pariente A; Shaffer CM; Malouf GG; Dureau P; Potey C; Funck-Brentano C; Roden DM; Moslehi JJ; Salem JE
Arch Cardiovasc Dis; 2020 Jan; 113(1):9-21. PubMed ID: 31685432
[TBL] [Abstract][Full Text] [Related]
13. Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
Hlavaty A; Roustit M; Montani D; Chaumais MC; Guignabert C; Humbert M; Cracowski JL; Khouri C
Br J Clin Pharmacol; 2022 Dec; 88(12):5227-5237. PubMed ID: 35679331
[TBL] [Abstract][Full Text] [Related]
14. Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®).
Batteux B; Bennis Y; Bodeau S; Masmoudi K; Hurtel-Lemaire AS; Kamel S; Gras-Champel V; Liabeuf S
Bone; 2021 Dec; 153():116137. PubMed ID: 34343739
[TBL] [Abstract][Full Text] [Related]
15. Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®.
Strumia M; Perrin ML; Patras de Compaigno E; Conte C; Montastruc F; Lapeyre-Mestre M; Sibaud V; Despas F
Therapie; 2022; 77(2):219-227. PubMed ID: 34973824
[TBL] [Abstract][Full Text] [Related]
16. Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
Al-Yafeai Z; Sondhi M; Vadlamudi K; Vyas R; Nadeem D; Alawadi M; Carvajal-González A; Ghoweba M; Ananthaneni A
Int J Cardiol; 2024 May; 402():131819. PubMed ID: 38301830
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
[TBL] [Abstract][Full Text] [Related]
18. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular safety of rapidly accelerated fibrosarcoma B-type and/or mitogen-activated extracellular signal-regulated kinase inhibitors: A mixed approach combining a meta-analysis and a pharmacovigilance disproportionality analysis.
Dolladille C; Font J; Bejan-Angoulvant T; Zaman K; Sassier M; Ezine E; Stefan A; Plane AF; Legallois D; Milliez P; Parienti JJ; Alexandre J
Arch Cardiovasc Dis; 2020; 113(6-7):420-432. PubMed ID: 32418884
[TBL] [Abstract][Full Text] [Related]
20. Analyses of Ocular Adverse Reactions Associated With Anticancer Drugs Based on the Japanese Pharmacovigilance Database.
Tanaka J; Koseki T; Kondo M; Ito Y; Yamada S
Anticancer Res; 2022 Sep; 42(9):4439-4451. PubMed ID: 36039456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
